Android app on Google Play

Charles River Laboratories (CRL) Tops Q2 EPS by 9c; Guides Higher

August 7, 2012 4:53 PM EDT Send to a Friend
Charles River Laboratories (NYSE: CRL) reported Q2 EPS of $0.75, $0.09 better than the analyst estimate of $0.66. Revenue for the quarter came in at $284.7 million versus the consensus estimate of $286.16 million.

Charles River Laboratories sees FY2012 EPS of $2.63-$2.73, versus prior guidance of $2.60-$2.70 and the consensus of $2.69.

For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.




You May Also Be Interested In


Related Categories

Earnings, Guidance

Related Entities

Earnings

Add Your Comment